GE and Intel invest $250 million to commercialize and develop innovative technologies for independent living and chronic disease management.
These home-based healthcare technologies will help the elderly to live independently and patients with chronic illnesses to manage their medical care from their home or a place of their choosing. GE Healthcare will sell and market the Intel Intel's Health Guide, a healthcare management tool designed for healthcare professionals who care for patients with chronic conditions, is included in the agreement. investment exceeding 250 million dollars, over the next five years, and that budget will be dedicated to the research and development of products with healthcare technologies for home use. In this regard, GE Healthcare and Intel will work together, combining their research resources to accelerate the innovation and commercialization of home healthcare technologies. They also have as objective to expand its current technological development programs in the area of home healthcare and independent living, which will include new areas such as fall prevention, medication adherence, sleep apnea, cardiovascular disease, diabetes and personal well-being monitoring.
On the other hand, both companies have announced their participation in research programs on home healthcare and independent living, with external funding. GE QuietCare is a passive remote control system of the activity and behavior of the elderly, alerting caregivers to changes that may indicate potential health problems or emergencies, such as a fall or the onset of an illness. Meanwhile, Intel Health Guide is a personal health system It combines a home device for the patient with an online interface that allows healthcare professionals to monitor patients at home and manage their care remotely. The Health Guide integrates vital sign monitoring, patient reminders, and communication tools such as videoconferencing and alerts.